5,982 results on '"von Willebrand Diseases"'
Search Results
2. A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients With VWD (EMPOWER)
3. ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
4. Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions (INDONESIA)
5. Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Von Willebrand Disease Patients (HMB/VWD)
6. Registry of Patients With Von WilLEbrand Disease Treated With Voncento® (OPALE)
7. The Severe Von Willebrand Disease (sVWD) Patient Registry
8. Early Check: Expanded Screening in Newborns
9. Impact of Von Willebrand Factor and Its Multimers on Angiogenesis (WILLANGIO)
10. The Lived Experience of People With Von Willebrand Disease (VWD360)
11. Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease
12. Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease VWD) Patients <6 Years of Age
13. Prevent Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN Trial
14. Minimize Menorrhagia in Women With Von Willebrand Disease (VWDMin)
15. ATHN 9: Severe VWD Natural History Study
16. Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI (APPOSE)
17. Post Trial Access Program of TAK-577 for Von Willebrand Disease (VWD)
18. Blutungsneigung und ihre Abklärung bei Kindern und Jugendlichen.
19. Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease
20. A Survey to Describe the Experience and Unmet Needs of Persons Living With Von Willebrand Disease (VWD) and Their Caregivers
21. Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment
22. A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)
23. A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
24. Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD
25. Severe Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition (HEMICOG)
26. Use of crushed tranexamic acid tablets in water for paediatric patients with bleeding disorders.
27. A noncanonical splicing variant c.875-5 T > G in von Willebrand factor causes in-frame exon skipping and type 2A von Willebrand disease.
28. Primary postpartum hemorrhage in women with von Willebrand disease and carriers of hemophilia: a retrospective analysis
29. Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases (VIDEO-BLEED)
30. A Study on Estimated Risks of Certain Adverse Events in Adults With Von Willebrand Disease (VWD) Treated With Veyvondi
31. Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients
32. World Bleeding Disorders Registry (WBDR)
33. Real-life Data of Constitutional Von Willebrand Disease in Western France (HOPSCOTCH-II)
34. Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study (HMB-BD)
35. A Study of Recombinant Von Willebrand Factor (rVWF) (TAK-577) in Children With Severe Von Willebrand Disease (vWD)
36. Decreasing Hemorrhage Risk in Children With Alagille Syndrome
37. To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)
38. Psychometrics of patient-reported outcomes measurement information system in von Willebrand disease, inherited platelet function disorders, and rare bleeding disorders
39. Cardiovascular and Venous Thromboembolism Disease in Patients With Von Willebrand Disease in the French West (TWIGO)
40. Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A (BCDI-XII)
41. Frequency of Hemorrhages Associated With the Functional Anomalies of Willebrand Factor in Emergency Patients (WITECMO-H)
42. Impact of Von Willebrand Factor-platelet Aggregates in Patients With Type 2B Disease (Von2B)
43. Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD) (VWF-phV)
44. Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding (PERICOLL)
45. Low VW Activity in Adolescent HMB (Low VWF)
46. Type 3 Von Willebrand International Registries Inhibitor Prospective Study (3WINTERSIPSEXT)
47. Impact of transcatheter aortic valve implantation on circulating von Willebrand factor in patients with severe aortic stenosis.
48. HRQoL and psychosocial aspects of burden on caregivers to children with moderate or severe von Willebrand disease.
49. Desmopressin (DDAVP) use in patients with von Willebrand disease: A single‐centre retrospective review of test response and clinical outcomes.
50. Characteristics, complications, and sites of bleeding among infants and toddlers less than 2 years of age with VWD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.